clinical trial · NCT06865482
Clinical Course Of Disease In Participants With FA-CM
Friedreich AtaxiaCardiomyopathy
brief summary
Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)
started
Sep 30, 2025
primary completion
Sep 1, 2027
completion
Sep 1, 2027
last updated
Sep 2, 2026
detailed description
Study LX2006-02 is a prospective, longitudinal, low-intervention, multicenter, global study aimed at characterizing the nature and rate of cardiac disease progression in participants with genetically confirmed FA.
official title
Characteristics And Clinical Course Of Disease In Participants With Cardiomyopathy Associated With Friedreich Ataxia (CLARITY-FA)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol